TRPV1 was shown to mediate itch-associated scratching and skin barrier dysfunction by regulating pruritogenic mediators (including TSLP, IL-31 and SP) in a 2,4-dinitrofluorobenzene (DNFB)-induced AD model (Tang et al., 2022). Here, TSLP is linked to Alzheimer disease.